Minutti, Carlos M. http://orcid.org/0000-0002-9663-1928
Piot, Cécile
Pereira da Costa, Mariana
Chakravarty, Probir
Rogers, Neil http://orcid.org/0000-0001-8977-7585
Huerga Encabo, Hector http://orcid.org/0000-0002-3723-8624
Cardoso, Ana http://orcid.org/0000-0002-4610-4337
Loong, Jane http://orcid.org/0000-0001-8718-6677
Bessou, Gilles
Mionnet, Cyrille
Langhorne, Jean http://orcid.org/0000-0002-2257-9733
Bonnet, Dominique http://orcid.org/0000-0002-4735-5226
Dalod, Marc http://orcid.org/0000-0002-6436-7966
Tomasello, Elena http://orcid.org/0000-0002-6839-5219
Reis e Sousa, Caetano http://orcid.org/0000-0001-7392-2119
Article History
Received: 5 January 2023
Accepted: 8 January 2024
First Online: 13 February 2024
Competing interests
: C.R.S. has an additional appointment as visiting professor in the Faculty of Medicine at Imperial College London and holds honorary professorships at University College London and King’s College London. C.R.S. is a founder of Adendra Therapeutics and owns stock options in or is a paid consultant for Adendra Therapeutics, Bicara Therapeutics, Montis Biosciences and Bicycle Therapeutics, all unrelated to this work. The other authors declare no competing interests.